Healthcare
•3734 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (3734)
| Company | Market Cap | Price |
|---|---|---|
|
BLRX
BioLineRx Ltd.
BioLineRx's lead oncology asset motixafortide (APHEXDA) places the company squarely in oncology with an approved stem cell mobilization therapy and ongoing cancer indications development.
|
$12.79M |
$2.43
+1.67%
|
|
CURX
Curanex Pharmaceuticals Inc Common Stock
Lead candidate Phyto-N targets inflammatory diseases, placing CURX in the Biotech - Immunology Therapeutics space.
|
$12.78M |
$0.45
+0.02%
|
|
KAPA
Kairos Pharma, Ltd.
Kairos Pharma is a clinical-stage biopharma focused on oncology therapies, including immunotherapies and cell therapies.
|
$12.73M |
$0.61
-0.98%
|
|
INTS
Intensity Therapeutics, Inc.
Company develops oncology-focused therapeutics (INT230-6.00) and operates in Biotech - Oncology.
|
$12.73M |
$5.33
+0.19%
|
|
SNGX
Soligenix, Inc.
ThermoVax vaccine thermostabilization platform and RiVax vaccine program place Soligenix in Vaccines.
|
$12.61M |
$1.25
+6.41%
|
|
BCDA
BioCardia, Inc.
CardiAMP and CardiALLO are BioCardia's direct cell-therapy programs (autologous and allogeneic) targeted for cardiovascular disease.
|
$12.52M |
$1.19
|
|
MODD
Modular Medical, Inc.
MODD directly manufactures insulin pumps (MODD1 and Pivot), a core medical device product category categorized under Medical Devices & Biometrics.
|
$12.42M |
$5.80
+20.44%
|
|
CLRB
Cellectar Biosciences, Inc.
Core product category: radiopharmaceuticals developed and marketed by Cellectar as radioconjugate therapies.
|
$12.38M |
$2.88
-4.32%
|
|
LIPO
Lipella Pharmaceuticals Inc.
Lipella's core metastable liposome drug delivery platform enables targeted, localized mucosal drug formulations.
|
$12.20M |
$0.31
|
|
RBOT
Vicarious Surgical Inc.
The company directly manufactures and sells surgical equipment in a robotic system for minimally invasive surgery.
|
$12.14M |
$2.02
-0.98%
|
|
RMSL
REMSleep Holdings, Inc.
RMSL designs and manufactures CPAP-based respiratory medical devices (DeltaWave), directly aligning with 'Medical Devices & Biometrics'.
|
$11.95M |
$0.01
|
|
TOMZ
TOMI Environmental Solutions, Inc.
Product category aligns with healthcare-themed medical devices and equipment, including disinfection hardware (SteraMist SIS/CES).
|
$11.83M |
$0.57
-2.90%
|
|
BIVI
BioVie Inc.
Bezisterim is described as an orally administered small molecule therapeutic targeting inflammation-driven insulin resistance in neurodegenerative diseases, aligning with 'Oral Small Molecule Therapeutics'.
|
$11.76M |
$1.56
+7.19%
|
|
GDTC
CytoMed Therapeutics Limited
Core business platform focuses on cell-based immunotherapies (gamma delta T cells, NK cells), aligning with Biotech - Cell Therapy.
|
$11.66M |
$1.00
-1.96%
|
|
PETV
PetVivo Holdings, Inc.
PetVivo's Spryng is a veterinarian-administered medical device/biomaterial for osteoarthritis in dogs and horses.
|
$11.56M |
$0.80
|
|
PVCT
Provectus Biopharmaceuticals, Inc.
VisiRose EyeCo focuses on ophthalmic topical RBS (PV-305) for infectious keratitis, an ophthalmic drug product.
|
$11.47M |
$0.05
|
|
TRAW
Traws Pharma, Inc.
Company is developing Antiviral Small-Molecule Therapeutics (ratutrelvir) for COVID-19 as a core antiviral program.
|
$11.44M |
$1.57
-3.09%
|
|
MDXH
MDxHealth S.A.
MDxHealth's portfolio includes liquid-based diagnostic tests (Select mdx, Resolve mdx, ExoDx) that fit the Liquid Biopsy category.
|
$11.43M |
$2.31
+4.77%
|
|
BFRG
Bullfrog AI Holdings, Inc. Common Stock
Engages in external collaborations/partnerships to provide AI-driven drug development services, akin to CRO-type engagements.
|
$11.34M |
$1.00
-7.35%
|
|
VASO
Vaso Corporation
Cardiology devices portfolio (EECP systems, Holter monitors, etc.) is a direct product line.
|
$11.24M |
$0.18
|
|
PLRZ
Polyrizon Ltd.
Polyrizon's core offering is a proprietary intranasal hydrogel-based drug delivery platform (Capture & Contain and Trap & Target) used to deliver allergy blockers and CNS-targeted APIs.
|
$11.18M |
$11.43
+4.48%
|
|
ELTP
Elite Pharmaceuticals, Inc.
Elite focuses on the development, manufacture, and sale of generic drugs across a broad pipeline.
|
$11.18M |
$0.38
|
|
DSY
Big Tree Cloud Holdings Limited
Provides OEM/ODM manufacturing services, i.e., contract manufacturing for others.
|
$10.91M |
$2.59
-1.89%
|
|
CVKD
Cadrenal Therapeutics, Inc. Common Stock
Cadrenal's tecarfarin is described as a novel oral small-molecule therapeutic, directly aligning with the 'Oral Small Molecule Therapeutics' tag.
|
$10.84M |
$5.50
+13.40%
|
|
BMGL
Basel Medical Group Ltd Ordinary Shares
BMGL provides hospital-style healthcare services, including inpatient/outpatient care via clinics and integrated care delivery.
|
$10.54M |
$0.55
-8.32%
|
|
SINT
Sintx Technologies, Inc.
Core business is manufacturing medical-grade silicon nitride materials used in medical devices, aligning with Medical Devices & Biometrics.
|
$10.36M |
$2.67
-0.37%
|
|
AMS
American Shared Hospital Services
AMS is directly operating outpatient radiation therapy centers (Direct Patient Services) in Rhode Island, Puebla, and other locations.
|
$10.34M |
$1.58
+5.33%
|
|
LFWD
Lifeward Ltd.
LFWD directly designs, manufactures, and sells medical devices (exoskeletons, anti-gravity systems, and rehabilitation solutions), fitting Medical Devices & Biometrics.
|
$10.03M |
$6.43
-3.67%
|
|
QURT
Quarta-Rad, Inc.
Geiger counters and radiation-detection devices are diagnostic/instrumentation equipment, mapping to Diagnostic Equipment.
|
$9.96M |
$0.65
|
|
EUDA
EUDA Health Holdings Limited
EUDA's core biotech activity is a stem cell platform and cell therapy development using iPSCs.
|
$9.77M |
$6.39
+7.58%
|
|
BCAB
BioAtla, Inc.
Oz-V and Mec-V are ADCs (CAB-ROR2-ADC, CAB-AXL-ADC) - major product modality.
|
$9.65M |
$0.17
+4.02%
|
|
NOTV
Inotiv, Inc.
Inotiv operates as a CRO delivering nonclinical drug discovery and development services, aligning with the Contract Research Organizations tag.
|
$9.52M |
$0.29
-1.66%
|
|
QNRX
Quoin Pharmaceuticals, Ltd.
Lead program targets a rare disease (Netherton Syndrome) and is developed by a biotech focused on rare diseases.
|
$9.48M |
$6.42
-2.43%
|
|
LHSW
Lianhe Sowell International Group Ltd Ordinary Shares
Exploration into medical applications via machine vision implies Medical Devices & Biometrics relevance.
|
$9.46M |
$0.18
-1.92%
|
|
CHEK
Check-Cap Ltd.
Check-Cap historically manufactured medical devices and biometric sensing technologies, including C-Scan components.
|
$9.42M |
$1.63
+1.24%
|
Showing page 33 of 38 (3734 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
